Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
Human and rabbit plasma contain a cholesteryl ester transfer protein (CETP) that promotes net mass transfers of cholesteryl esters from high density lipoproteins (HDL) to other plasma lipoprotein fractions. As predicted, inhibition of CETP in both humans and rabbits increases the concentration of ch...
Main Authors: | Philip J. Barter, Kerry-Anne Rye |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-09-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520418218 |
Similar Items
-
Cholesteryl ester transfer protein:Ace of Spades, Queen of Hearts, or The Joker?
by: Norman Eric Miller
Published: (2015-07-01) -
Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasianss⃞
by: Wim A. van der Steeg, et al.
Published: (2007-03-01) -
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
by: Guoqing Cao, et al.
Published: (2011-12-01) -
Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors
by: Jing-Kang Shen, et al.
Published: (2012-05-01) -
Cholesteryl ester transfer protein and its inhibitors
by: Sudichhya Shrestha, et al.
Published: (2018-01-01)